Back to Resources
Market Highlights
-
Gilead advanced awareness of primary biliary cholangitis through disease education while positioning Livdelzi with clinical results, treatment benefits, and patient support resources.
-
GSK announced the FDA approval of Lynavoy for a type of liver disease.
Questions about this SnapShot or other markets?
U.S. MARKETS
Christine Alongi
alongi@dtwresearch.com
GLOBAL MARKETS
Robin Cefalo
cefalo@dtwresearch.com
SOCIAL MEDIA MARKETS
Andrew Carney
carney@dtwresearch.com